Pfizer Inc. and Astellas Pharma Inc. published favorable baseline results from the Phase 3 EMBARK trial evaluating XTANDI® in men with hormone-responsive, non-metastatic prostate cancer at high risk for biochemical recurrence. Patients participating in the trial were randomized to one of three study arms: XTANDI plus leuprolide, placebo plus leuprolide […]
Trending News
Tandem Diabetes Care Announces NEJM Publication of Study Demonstrating Increased Time in Range in Young Children with Type 1 Diabetes Using the t:slim X2 Insulin Pump with Control-IQ Technology
Tandem Diabetes Care, Inc., a leader in insulin delivery and diabetes technology, today announced that it has published the results of the Pediatric Artificial Pancreas (PEDAP) clinical trial in the New England Journal of Medicine. Tag range for children aged 2-5 with t*:With advanced Control IQ hybrid closed-loop technology**, the […]
Humana’s Economic Impact in Florida Totals $48 Billion
Health and wellness leader Humana Inc. will contribute a total of $48 billion to Florida’s overall economic impact in 2022. Additionally, Florida has more Humana employees and healthcare plan members than any other state. Commissioned by Humana from the Center for Economic Forecasting and Analysis at Florida State University, the […]
Fifth Third Announces Acquisition of Big Data Healthcare, a Payments Company Serving National Health Systems, Physicians
Fifth Third Bancorp has announced a definitive agreement to acquire Big Data Healthcare, a technology solutions provider for healthcare payments and remittances. The transaction complements nationwide healthcare revenue cycle capabilities that address diverse and complex customer needs while building on Fifth Third’s digital innovation legacy and focusing on the healthcare […]
Celltrion Healthcare Presents Efficacy and Safety Data From Global Phase III LIBERTY Trial, at the 18th ECCO Congress
Celltrion Healthcare has presented new data demonstrating the efficacy and safety of subcutaneous infliximab (SC) (CT-P13 SC) in patients with inflammatory bowel disease (IBD). The data were presented in a digital oral presentation and poster presentations at the 18th Annual General Meeting of the European Crohn’s Disease and Colitis Organization […]
Hologram Science and Haleon team up to create a personalized nutritional innovation process
Hologram Science, a consumer-focused healthcare technology company dedicated to creating personalized holistic nutrition solutions, has established a strategic partnership with Haleon, a leading company. consumer health world. The collaboration focuses on innovation to address consumer health concerns in areas such as healthy aging. The partnership will also leverage Hologram Science’s […]
Philips forms strategic collaborations with industry leaders to inspire action toward net-zero healthcare
The European Association of Radiology, Harmless Healthcare and other organizations are working with Philips at ECR 2023 and beyond to accelerate research, collaboration and education related to decarbonization in X-ray If healthcare were a country, it would rank fifth in the world in CO₂ emissions, accounting for more than 4% […]
One Medical Joins Amazon to Make It Easier for People to Get and Stay Healthier
Amazon and 1Life Healthcare, Inc. announced that Amazon has completed its acquisition of One Medical. One Medical’s virtual in-office and 24/7 care services, on-site lab and preventive care programs, chronic care management, common illnesses and mental health issues have been pleasing people for 15 years. Together Amazon and One Medical […]
Lunit and Agfa Announce Lunit INSIGHT CXR’s Integration in Agfa’s MUSICA® Workstation; Demonstration and Presentation to be Showcased at ECR 2023
Lunit and Agfa Radiology Solutions today announced the integration of Lunit’s AI solution for chest radiology, Lunit INSIGHT CXR, into the MUSICA® workstation. Agfa will demonstrate the integrated product at the upcoming European Congress of Radiology (ECR) 2023, to be held in Vienna, Austria, from 1 to 5 March. Lunit […]
Agios Reports Fourth Quarter and Full Year 2022 Financial Results
Agios Pharmaceuticals, Inc., the leader in pioneering cellular metabolic therapies for rare diseases, today announced business highlights and financial results for the fourth quarter and fiscal year ended. ends on December 31, 2022. “Over the past year, Agios has made significant progress toward our vision of transforming the lives of […]
